BIO-key Intl (NASDAQ:BKYI) reported quarterly losses of $(0.16) per share. This is a 50 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $1.61 million which beat the analyst consensus estimate of $1.30 million by 23.62 percent. This is a 26.32 percent decrease over sales of $2.18 million the same period last year.